Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 262

1.

Key factors for sustainable integration of pharmacists in team-based primary care physician practices.

Dombrowski SK, Bacci JL, Klatt PM, Osborne M, Castelli G, Burns A, Somma McGivney MA.

J Am Pharm Assoc (2003). 2019 May - Jun;59(3):439-448.e1. doi: 10.1016/j.japh.2019.02.005. Epub 2019 Apr 11.

PMID:
30982772
2.

Outcomes in an Interdisciplinary Diabetes Clinic in Rural Primary Care.

King DE, Petrone AB, Alcantara FM, Elavsky MM, Prestoza MO, Siebart J, Castelli G.

South Med J. 2019 Apr;112(4):205-209. doi: 10.14423/SMJ.0000000000000960.

PMID:
30943537
3.

Leishmania infantum-specific IFN-γ production in stimulated blood from cats living in areas where canine leishmaniosis is endemic.

Priolo V, Martínez-Orellana P, Pennisi MG, Masucci M, Prandi D, Ippolito D, Bruno F, Castelli G, Solano-Gallego L.

Parasit Vectors. 2019 Mar 26;12(1):133. doi: 10.1186/s13071-019-3386-y.

4.

Emerging Therapies for Acute Myelogenus Leukemia Patients Targeting Apoptosis and Mitochondrial Metabolism.

Castelli G, Pelosi E, Testa U.

Cancers (Basel). 2019 Feb 22;11(2). pii: E260. doi: 10.3390/cancers11020260. Review.

5.

Is the Slow Vital Capacity Clinically Useful to Uncover Airflow Limitation in Subjects With Preserved FEV1/FVC Ratio?

Saint-Pierre M, Ladha J, Berton DC, Reimao G, Castelli G, Marillier M, Bernard AC, O'Donnell DE, Neder JA.

Chest. 2019 Feb 12. pii: S0012-3692(19)30143-6. doi: 10.1016/j.chest.2019.02.001. [Epub ahead of print]

PMID:
30768928
6.

Exosome secretion by Leishmania infantum modulate the chemotactic behavior and cytokinic expression creating an environment permissive for early infection.

Castelli G, Bruno F, Saieva L, Alessandro R, Galluzzi L, Diotallevi A, Vitale F.

Exp Parasitol. 2019 Mar;198:39-45. doi: 10.1016/j.exppara.2019.01.014. Epub 2019 Feb 1.

PMID:
30716304
7.

What's the best treatment setting for stable PE patients?

Schaffer M, Castelli G.

J Fam Pract. 2018 Dec;67(12):777-779.

8.

Fog collection as a strategy to sequester carbon in drylands.

Certini G, Castelli G, Bresci E, Calamini G, Pierguidi A, Villegas Paredes LN, Salbitano F.

Sci Total Environ. 2019 Mar 20;657:391-400. doi: 10.1016/j.scitotenv.2018.12.038. Epub 2018 Dec 5.

PMID:
30550903
9.

The small-molecule compound AC-73 targeting CD147 inhibits leukemic cell proliferation, induces autophagy and increases the chemotherapeutic sensitivity of acute myeloid leukemia cells.

Spinello I, Saulle E, Quaranta MT, Pasquini L, Pelosi E, Castelli G, Ottone T, Voso MT, Testa U, Labbaye C.

Haematologica. 2019 May;104(5):973-985. doi: 10.3324/haematol.2018.199661. Epub 2018 Nov 22.

10.

Examining an Evidence-Based Medicine Culture in Residency Education.

Epling JW, Heidelbaugh JJ, Woolever D, Castelli G, Mi M, Mader EM, Morley CP.

Fam Med. 2018 Nov;50(10):751-755. doi: 10.22454/FamMed.2018.576501.

PMID:
30428103
11.

Predictors of Major Bleeding Among Working-Age Adults with Atrial Fibrillation: Evaluating the Effects of Potential Drug-drug Interactions and Switching from Warfarin to Non-vitamin K Oral Anticoagulants.

Feng X, Sambamoorthi U, Innes K, Castelli G, LeMasters T, Xiong L, Williams MU, Tan X.

Cardiovasc Drugs Ther. 2018 Dec;32(6):591-600. doi: 10.1007/s10557-018-6825-7.

PMID:
30315487
12.

Genetic Abnormalities, Clonal Evolution, and Cancer Stem Cells of Brain Tumors.

Testa U, Castelli G, Pelosi E.

Med Sci (Basel). 2018 Oct 2;6(4). pii: E85. doi: 10.3390/medsci6040085. Review.

13.

Prediction of Isocitrate Dehydrogenase Genotype in Brain Gliomas with MRI: Single-Shell versus Multishell Diffusion Models.

Figini M, Riva M, Graham M, Castelli GM, Fernandes B, Grimaldi M, Baselli G, Pessina F, Bello L, Zhang H, Bizzi A.

Radiology. 2018 Dec;289(3):788-796. doi: 10.1148/radiol.2018180054. Epub 2018 Oct 2.

14.

Crisaborole (Eucrisa) for Mild to Moderate Atopic Dermatitis.

Castelli G, Schaffer M.

Am Fam Physician. 2018 Sep 15;98(6):379-380. No abstract available.

PMID:
30215912
15.

Pharmacist-Delivered Comprehensive Medication Management Within Family Medicine Practices An Evaluation of the SCRIPT Project.

Castelli G, Bacci JL, Dombrowski SK, Osborne M, Difilippo A, Klatt PM, McGivney MS.

Fam Med. 2018 Sep;50(8):605-612. doi: 10.22454/FamMed.2018.391124.

16.

Healthcare Utilization and Expenditures in Working-Age Adults with Atrial Fibrillation: The Effect of Switching from Warfarin to Non-Vitamin K Oral Anticoagulants.

Feng X, Sambamoorthi U, Innes K, LeMasters T, Castelli G, Dwibedi N, Tan X.

Am J Cardiovasc Drugs. 2018 Dec;18(6):513-520. doi: 10.1007/s40256-018-0296-x.

PMID:
30144015
17.

PURL: Time to switch to nonsterile gloves for these procedures?

Castelli G, Friedlander MP.

J Fam Pract. 2018 Aug;67(8):507-508.

18.

Lung Cancers: Molecular Characterization, Clonal Heterogeneity and Evolution, and Cancer Stem Cells.

Testa U, Castelli G, Pelosi E.

Cancers (Basel). 2018 Jul 27;10(8). pii: E248. doi: 10.3390/cancers10080248. Review.

19.

miR-146 and miR-155: Two Key Modulators of Immune Response and Tumor Development.

Testa U, Pelosi E, Castelli G, Labbaye C.

Noncoding RNA. 2017 Jun 26;3(3). pii: E22. doi: 10.3390/ncrna3030022. Review.

20.

Colorectal cancer: genetic abnormalities, tumor progression, tumor heterogeneity, clonal evolution and tumor-initiating cells.

Testa U, Pelosi E, Castelli G.

Med Sci (Basel). 2018 Apr 13;6(2). pii: E31. doi: 10.3390/medsci6020031. Review.

21.

PURLs: Does fish oil during pregnancy help prevent asthma in kids?

Neutze D, Evans KL, Koenig M, Castelli G, Mounsey A.

J Fam Pract. 2018 Feb;67(2):100-102.

22.

Ovarian Cancers: Genetic Abnormalities, Tumor Heterogeneity and Progression, Clonal Evolution and Cancer Stem Cells.

Testa U, Petrucci E, Pasquini L, Castelli G, Pelosi E.

Medicines (Basel). 2018 Feb 1;5(1). pii: E16. doi: 10.3390/medicines5010016. Review.

23.

Targeting histone methyltransferase and demethylase in acute myeloid leukemia therapy.

Castelli G, Pelosi E, Testa U.

Onco Targets Ther. 2017 Dec 28;11:131-155. doi: 10.2147/OTT.S145971. eCollection 2018. Review.

24.

"Click" on PLGA-PEG and hyaluronic acid: Gaining access to anti-leishmanial pentamidine bioconjugates.

Scala A, Piperno A, Micale N, Mineo PG, Abbadessa A, Risoluti R, Castelli G, Bruno F, Vitale F, Cascio A, Grassi G.

J Biomed Mater Res B Appl Biomater. 2018 Nov;106(8):2778-2785. doi: 10.1002/jbm.b.34058. Epub 2017 Dec 8.

PMID:
29219244
25.

PURLs: Does azithromycin have a role in cesarean sections?

Castelli G, Flaherty A, Jarrett JB.

J Fam Pract. 2017 Dec;66(12):762-764.

26.

Melanoma: Genetic Abnormalities, Tumor Progression, Clonal Evolution and Tumor Initiating Cells.

Testa U, Castelli G, Pelosi E.

Med Sci (Basel). 2017 Nov 20;5(4). pii: E28. doi: 10.3390/medsci5040028. Review.

27.

Pancreatic Cancer: Molecular Characterization, Clonal Evolution and Cancer Stem Cells.

Pelosi E, Castelli G, Testa U.

Biomedicines. 2017 Nov 18;5(4). pii: E65. doi: 10.3390/biomedicines5040065. Review.

28.

Effects of trans-stilbene and terphenyl compounds on different strains of Leishmania and on cytokines production from infected macrophages.

Bruno F, Castelli G, Vitale F, Giacomini E, Roberti M, Colomba C, Cascio A, Tolomeo M.

Exp Parasitol. 2018 Jan;184:31-38. doi: 10.1016/j.exppara.2017.11.004. Epub 2017 Nov 14.

PMID:
29154845
29.

Comparison of long-term outcome in anthracycline-related versus idiopathic dilated cardiomyopathy: a single centre experience.

Fornaro A, Olivotto I, Rigacci L, Ciaccheri M, Tomberli B, Ferrantini C, Coppini R, Girolami F, Mazzarotto F, Chiostri M, Milli M, Marchionni N, Castelli G.

Eur J Heart Fail. 2018 May;20(5):898-906. doi: 10.1002/ejhf.1049. Epub 2017 Nov 16.

30.

PURLs: When to "CAP" off treatment for pneumonia.

Castelli G, Jarrett JB.

J Fam Pract. 2017 Oct;66(10):629-631.

31.

Mechanisms of anti-cancer effects of ascorbate: Cytotoxic activity and epigenetic modulation.

Mastrangelo D, Pelosi E, Castelli G, Lo-Coco F, Testa U.

Blood Cells Mol Dis. 2018 Mar;69:57-64. doi: 10.1016/j.bcmd.2017.09.005. Epub 2017 Sep 21. Review.

PMID:
28954710
32.

Esophageal Cancer: Genomic and Molecular Characterization, Stem Cell Compartment and Clonal Evolution.

Testa U, Castelli G, Pelosi E.

Medicines (Basel). 2017 Sep 14;4(3). pii: E67. doi: 10.3390/medicines4030067. Review.

33.

Liver Cancer: Molecular Characterization, Clonal Evolution and Cancer Stem Cells.

Castelli G, Pelosi E, Testa U.

Cancers (Basel). 2017 Sep 20;9(9). pii: E127. doi: 10.3390/cancers9090127. Review.

34.

Suspected cutaneous leishmaniasis in a sample of Westerns Sicily residents: what correlation with occupation?

Verso MG, Vitale F, Castelli G, Bruno F, Migliazzo A, Bongiorno MR, Santi F, Pistone G, Amodio E, Picciotto D.

Med Lav. 2017 Apr 21;108(2):123-129. doi: 10.23749/mdl.v108i2.5665.

PMID:
28446739
35.

High-dose ascorbate and arsenic trioxide selectively kill acute myeloid leukemia and acute promyelocytic leukemia blasts in vitro.

Noguera NI, Pelosi E, Angelini DF, Piredda ML, Guerrera G, Piras E, Battistini L, Massai L, Berardi A, Catalano G, Cicconi L, Castelli G, D'Angiò A, Pasquini L, Graziani G, Fioritoni G, Voso MT, Mastrangelo D, Testa U, Lo-Coco F.

Oncotarget. 2017 May 16;8(20):32550-32565. doi: 10.18632/oncotarget.15925.

36.

Safety of Tofacitinib in the Treatment of Rheumatoid Arthritis in Latin America Compared With the Rest of the World Population.

Castañeda OM, Romero FJ, Salinas A, Citera G, Mysler E, Rillo O, Radominski SC, Cardiel MH, Jaller JJ, Alvarez-Moreno C, Ponce de Leon D, Castelli G, García EG, Kwok K, Rojo R.

J Clin Rheumatol. 2017 Jun;23(4):193-199. doi: 10.1097/RHU.0000000000000498.

PMID:
28145906
37.

Rates of Nonsteroidal Anti-Inflammatory Drug Use in Patients with Established Cardiovascular Disease: A Retrospective, Cross-Sectional Study from NHANES 2009-2010.

Castelli G, Petrone A, Xiang J, Shrader C, King D.

Am J Cardiovasc Drugs. 2017 Jun;17(3):243-249. doi: 10.1007/s40256-016-0212-1.

38.

Targeted therapies in the treatment of adult acute myeloid leukemias: current status and future perspectives.

Castelli G, Pelosi E, Testa U.

Int J Hematol Oncol. 2016 Dec;5(4):143-164. doi: 10.2217/ijh-2016-0011. Epub 2017 Feb 7. Review.

39.

Conditioned medium from human umbilical vein endothelial cells markedly improves the proliferation and differentiation of circulating endothelial progenitors.

Castelli G, Parolini I, Cerio AM, D'Angiò A, Pasquini L, Carollo M, Sargiacomo M, Testa U, Pelosi E.

Blood Cells Mol Dis. 2016 Oct;61:58-65. doi: 10.1016/j.bcmd.2016.07.007. Epub 2016 Aug 18.

PMID:
27667168
40.

Clinical Pharmacists in Family Medicine Residency Programs: Tackling the Billing Barrier.

Castelli G.

Fam Med. 2016 Sep;48(8):657-8. No abstract available.

41.

Endothelial progenitor cells in hematologic malignancies.

Testa U, Saulle E, Castelli G, Pelosi E.

Stem Cell Investig. 2016 Jul 1;3:26. doi: 10.21037/sci.2016.06.07. eCollection 2016. Review.

42.

Oxidative stress and hypoxia in normal and leukemic stem cells.

Testa U, Labbaye C, Castelli G, Pelosi E.

Exp Hematol. 2016 Jul;44(7):540-60. doi: 10.1016/j.exphem.2016.04.012. Epub 2016 May 12. Review.

PMID:
27179622
43.

DON'T QUIT ON YOUR SMOKERS. Persistence pays off when it comes to free nicotine replacement.

Castelli G.

W V Med J. 2016 Mar-Apr;112(2):13. No abstract available.

PMID:
27025112
44.

In vitro antileishmanial activity of trans-stilbene and terphenyl compounds.

Castelli G, Bruno F, Vitale F, Roberti M, Colomba C, Giacomini E, Guidotti L, Cascio A, Tolomeo M.

Exp Parasitol. 2016 Jul;166:1-9. doi: 10.1016/j.exppara.2016.03.007. Epub 2016 Mar 4.

PMID:
26953250
45.

Relationship between electrocardiographic findings and Cardiac Magnetic Resonance phenotypes in patients with Hypertrophic Cardiomyopathy.

Fronza M, Raineri C, Valentini A, Bassi EM, Scelsi L, Buscemi ML, Turco A, Castelli G, Ghio S, Visconti LO.

Int J Cardiol Heart Vasc. 2016 Mar 2;11:7-11. doi: 10.1016/j.ijcha.2016.02.001. eCollection 2016 Jun.

46.

Impact of Genotype on the Occurrence of Atrial Fibrillation in Patients With Hypertrophic Cardiomyopathy.

Bongini C, Ferrantini C, Girolami F, Coppini R, Arretini A, Targetti M, Bardi S, Castelli G, Torricelli F, Cecchi F, Ackerman MJ, Padeletti L, Poggesi C, Olivotto I.

Am J Cardiol. 2016 Apr 1;117(7):1151-9. doi: 10.1016/j.amjcard.2015.12.058. Epub 2016 Jan 14.

PMID:
26869393
47.

[The early management of the sepsis: use of a guidelines document in hospital. Experience at "Carlo Poma" Hospital in Mantova].

Gattuso G, Benazzi D, Ceruti R, Chiarelli C, Nespeca M, Dall'Oglio D, Lonati G, Marchioni M, Sgarioto V, Storti P, Tomasoni D, Castelli G, Costa P.

Recenti Prog Med. 2015 Nov;106(11):570-5. doi: 10.1701/2074.22496. Italian.

PMID:
26668043
48.

Prognostic role of N-terminal pro-brain natriuretic peptide in asymptomatic hypertensive and diabetic patients in primary care: impact of age and gender : Results from the PROBE-HF study.

Ballo P, Betti I, Barchielli A, Balzi D, Castelli G, De Luca L, Gheorghiade M, Zuppiroli A.

Clin Res Cardiol. 2016 May;105(5):421-31. doi: 10.1007/s00392-015-0937-x. Epub 2015 Nov 7.

PMID:
26547915
49.

Targeting LSCs through membrane antigens selectively or preferentially expressed on these cells.

Pelosi E, Castelli G, Testa U.

Blood Cells Mol Dis. 2015 Dec;55(4):336-46. doi: 10.1016/j.bcmd.2015.07.015. Epub 2015 Jul 26. Review.

PMID:
26460257
50.

Clinical Spectrum, Therapeutic Options, and Outcome of Advanced Heart Failure in Hypertrophic Cardiomyopathy.

Pasqualucci D, Fornaro A, Castelli G, Rossi A, Arretini A, Chiriatti C, Targetti M, Girolami F, Corda M, Orrù P, Matta G, Stefàno P, Cecchi F, Porcu M, Olivotto I.

Circ Heart Fail. 2015 Nov;8(6):1014-21. doi: 10.1161/CIRCHEARTFAILURE.114.001843. Epub 2015 Oct 7.

PMID:
26446673

Supplemental Content

Loading ...
Support Center